Home › Funds › Tri Locum Partners LP › MDGL
Tri Locum Partners LP position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Tri Locum Partners LP reported holding 68,273 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$36.7M, representing 4.51% of its reported portfolio and ranking #10 among its reported holdings. Tri Locum Partners LP has disclosed MDGL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tri Locum Partners LP's MDGL position evolved
Tri Locum Partners LP first disclosed a stake in MDGL in Q3 2023 at 33,761 shares (US$4.9M). The position peaked in Q1 2026 at 103,288 shares, worth US$54.1M. Across 12 filings, Tri Locum Partners LP increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 68,273 shares valued at US$36.7M — a reduction of -35,015 shares quarter over quarter.. Notable position changes include a 109% increase in Q1 2024 (shares rose 5% over the following quarter), a 158% increase in Q2 2025 (shares rose 52% over the following quarter), a 34% trim in Q2 2026 (shares fell 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 33.76K | $4.93M | New |
| Q4 2023 | 25.52K | $5.91M | Reduce |
| Q1 2024 | 53.35K | $14.25M | Add |
| Q2 2024 | 65.35K | $18.31M | Add |
| Q3 2024 | 43.29K | $9.19M | Reduce |
| Q4 2024 | 47.47K | $14.65M | Add |
| Q1 2025 | 37.87K | $12.54M | Reduce |
| Q2 2025 | 97.77K | $29.59M | Add |
| Q3 2025 | 67.71K | $31.05M | Reduce |
| Q4 2025 | 86.02K | $50.09M | Add |
| Q1 2026 | 103.29K | $54.07M | Add |
| Q2 2026 | 68.27K | $36.66M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDGL and 13F data
MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDGL
- BAKER BROS. ADVISORS LP 2.14M sh · $1.15B · Q2 2026
- RTW INVESTMENTS, LP 1.99M sh · $1.07B · Q2 2026
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M sh · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M sh · $984.41M · Q2 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M sh · $719.52M · Q2 2026
- ARMISTICE CAPITAL, LLC 288.00K sh · $154.64M · Q2 2026
- Rock Springs Capital Management LP 175.00K sh · $93.97M · Q2 2026
- Erste Asset Management GmbH 110.21K sh · $58.11M · Q2 2026
More on Tri Locum Partners LP
FAQ
How long has Tri Locum Partners LP held MDGL?
Tri Locum Partners LP has disclosed MDGL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Tri Locum Partners LP's current position in MDGL?
As of Q2 2026, Tri Locum Partners LP holds 68.27K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $36.66M, representing 4.51% of its reported portfolio and ranking #10.
Has Tri Locum Partners LP been buying or selling MDGL?
In the latest 13F filing (Q2 2026), Tri Locum Partners LP reduced its position in MDGL. The position peaked in Q1 2026 at 103.29K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.